Is BCRX stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 17th of October 2014, BioCryst Pharmaceuticals had a stock price of $11.58. If you invested back then, your return now would be a loss of $-4.01 per share or -34.63%
Yes, the average daily trading liquidity for BioCryst Pharmaceuticals is $17.85 million. You should therefore be able to get in and out of your positions relatively fast.
BioCryst Pharmaceuticals has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for BioCryst Pharmaceuticals to be high [1 out of 1]